|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-10-8
|
|
pubmed:abstractText |
We conducted a phase I dose escalation study to determine the maximum tolerated dose, recommended dose, and safety profile of a biweekly gemcitabine and carboplatin combination regimen in the treatment of patients with completely resected nonsmall cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1537-453X
|
|
pubmed:author |
pubmed-author:AokiHarukaH,
pubmed-author:IijimaHironobuH,
pubmed-author:ImaiHisaoH,
pubmed-author:InoueTerukiT,
pubmed-author:IshidaEmiE,
pubmed-author:IshiharaShin-ichiS,
pubmed-author:IwasakiYasukiY,
pubmed-author:KawashimaOsamuO,
pubmed-author:KobayashiGoG,
pubmed-author:MoriMasatomoM,
pubmed-author:SaitoRyuseiR,
pubmed-author:SatoKojiK,
pubmed-author:TomizawaYoshioY,
pubmed-author:WatanabeSatoruS,
pubmed-author:YamadaHidenoriH,
pubmed-author:YatomiMasakiyoM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
498-502
|
|
pubmed:meshHeading |
pubmed-meshheading:17921710-Adult,
pubmed-meshheading:17921710-Aged,
pubmed-meshheading:17921710-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17921710-Carboplatin,
pubmed-meshheading:17921710-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17921710-Deoxycytidine,
pubmed-meshheading:17921710-Dose-Response Relationship, Drug,
pubmed-meshheading:17921710-Drug Administration Schedule,
pubmed-meshheading:17921710-Female,
pubmed-meshheading:17921710-Hematologic Diseases,
pubmed-meshheading:17921710-Humans,
pubmed-meshheading:17921710-Leukopenia,
pubmed-meshheading:17921710-Life Expectancy,
pubmed-meshheading:17921710-Lung Neoplasms,
pubmed-meshheading:17921710-Male,
pubmed-meshheading:17921710-Middle Aged,
pubmed-meshheading:17921710-Neoplasm Staging,
pubmed-meshheading:17921710-Neutropenia
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer.
|
|
pubmed:affiliation |
Department of Respiratory Medicine, National Nishigunma Hospital, Shibukawa, Gunma, Japan. ytomizawa@netnngh.hosp.go.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
